Literature DB >> 21826385

Upper limb function in adults with Duchenne muscular dystrophy.

Bart Bartels1, Robert F Pangalila, Michael P Bergen, Nicolle A M Cobben, Henk J Stam, Marij E Roebroeck.   

Abstract

OBJECTIVE: To determine upper limb function and associated factors in adults with Duchenne muscular dystrophy.
DESIGN: Cross-sectional study.
SUBJECTS: A sample of 70 men with Duchenne muscular dystrophy (age range 20-43 years).
METHODS: General motor function and, in particular, upper limb distal motor function, were assessed with the Motor Function Measure. Muscle strength and range of motion of the upper limb were evaluated using hand-held dynamo-metry, manual muscle-testing and goniometry. Associations were studied using Spearman's correlation coefficients and multiple linear regression analysis.
RESULTS: General motor function was severely impaired. Wide variability was found in distal motor function, muscle strength and range of motion of the upper limb, especially in early adulthood. Muscle strength and range of motion explained 76% of the variance in upper limb distal motor function.
CONCLUSION: This study illustrates a large variability in upper limb function in adult patients with Duchenne muscular dystrophy, and identifies muscle strength and range of motion as factors strongly associated with upper limb function. These results suggest that preserving muscle strength and range of motion in Duchenne patients might be relevant for a better outcome of distal motor function of the upper limb when adult.

Entities:  

Mesh:

Year:  2011        PMID: 21826385     DOI: 10.2340/16501977-0841

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  23 in total

1.  Pulmonary and upper limbs function in children with early stage Duchenne muscular dystrophy compared to their healthy peers.

Authors:  Numan Bulut; Güllü Aydın; İpek Alemdaroğlu-Gürbüz; Ayşe Karaduman; Öznur Yılmaz
Journal:  Braz J Phys Ther       Date:  2020-06-05       Impact factor: 3.377

2.  Validity, Reliability, and Sensitivity of a 3D Vision Sensor-based Upper Extremity Reachable Workspace Evaluation in Neuromuscular Diseases.

Authors:  Jay J Han; Gregorij Kurillo; R Ted Abresch; Alina Nicorici; Ruzena Bajcsy
Journal:  PLoS Curr       Date:  2013-12-12

Review 3.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.

Authors:  David J Birnkrant; Katharine Bushby; Carla M Bann; Susan D Apkon; Angela Blackwell; David Brumbaugh; Laura E Case; Paula R Clemens; Stasia Hadjiyannakis; Shree Pandya; Natalie Street; Jean Tomezsko; Kathryn R Wagner; Leanne M Ward; David R Weber
Journal:  Lancet Neurol       Date:  2018-02-03       Impact factor: 44.182

4.  Reliability, validity and description of timed performance of the Jebsen-Taylor Test in patients with muscular dystrophies.

Authors:  Mariana Cunha Artilheiro; Francis Meire Fávero; Fátima Aparecida Caromano; Acary de Souza Bulle Oliveira; Nelson Carvas; Mariana Callil Voos; Cristina Dos Santos Cardoso de Sá
Journal:  Braz J Phys Ther       Date:  2017-12-08       Impact factor: 3.377

5.  Reachable workspace in facioscapulohumeral muscular dystrophy (FSHD) by Kinect.

Authors:  Jay J Han; Gregorij Kurillo; Richard T Abresch; Evan de Bie; Alina Nicorici; Ruzena Bajcsy
Journal:  Muscle Nerve       Date:  2014-11-19       Impact factor: 3.217

6.  Results of a two-year pilot study of clinical outcome measures in collagen VI- and laminin alpha2-related congenital muscular dystrophies.

Authors:  Katherine G Meilleur; Minal S Jain; Linda S Hynan; Ching-Yi Shieh; Eunice Kim; Melissa Waite; Michelle McGuire; Courtney Fiorini; Allan M Glanzman; Marion Main; Kristy Rose; Tina Duong; Roxanna Bendixen; Melody M Linton; Irene C Arveson; Carmel Nichols; Kelly Yang; Kenneth H Fischbeck; Kathryn R Wagner; Kathryn North; Ami Mankodi; Christopher Grunseich; Elizabeth J Hartnett; Michaele Smith; Sandra Donkervoort; Alice Schindler; Angela Kokkinis; Meganne Leach; A Reghan Foley; James Collins; Francesco Muntoni; Anne Rutkowski; Carsten G Bönnemann
Journal:  Neuromuscul Disord       Date:  2014-09-28       Impact factor: 4.296

7.  A Movement Monitor Based on Magneto-Inertial Sensors for Non-Ambulant Patients with Duchenne Muscular Dystrophy: A Pilot Study in Controlled Environment.

Authors:  Anne-Gaëlle Le Moing; Andreea Mihaela Seferian; Amélie Moraux; Mélanie Annoussamy; Eric Dorveaux; Erwan Gasnier; Jean-Yves Hogrel; Thomas Voit; David Vissière; Laurent Servais
Journal:  PLoS One       Date:  2016-06-07       Impact factor: 3.240

8.  Gastrocnemius medialis muscle architecture and physiological cross sectional area in adult males with Duchenne muscular dystrophy.

Authors:  C I Morse; J Smith; A Denny; J Tweedale; N D Searle
Journal:  J Musculoskelet Neuronal Interact       Date:  2015-06       Impact factor: 2.041

9.  European Cross-Sectional Survey of Current Care Practices for Duchenne Muscular Dystrophy Reveals Regional and Age-Dependent Differences.

Authors:  Julia Vry; Kathrin Gramsch; Sunil Rodger; Rachel Thompson; Birgit F Steffensen; Jes Rahbek; Sam Doerken; Adrian Tassoni; María de Los Angeles Beytía; Velina Guergueltcheva; Teodora Chamova; Ivailo Tournev; Anna Kostera-Pruszczyk; Anna Kaminska; Anna Lusakowska; Lenka Mrazova; Lenka Pavlovska; Jana Strenkova; Petr Vondráček; Marta Garami; Veronika Karcagi; Ágnes Herczegfalvi; Katherine Bushby; Hanns Lochmüller; Janbernd Kirschner
Journal:  J Neuromuscul Dis       Date:  2016-11-29

10.  Upper limb strength and function changes during a one-year follow-up in non-ambulant patients with Duchenne Muscular Dystrophy: an observational multicenter trial.

Authors:  Andreea Mihaela Seferian; Amélie Moraux; Mélanie Annoussamy; Aurélie Canal; Valérie Decostre; Oumar Diebate; Anne-Gaëlle Le Moing; Teresa Gidaro; Nicolas Deconinck; Frauke Van Parys; Wendy Vereecke; Sylvia Wittevrongel; Michèle Mayer; Kim Maincent; Isabelle Desguerre; Christine Thémar-Noël; Jean-Marie Cuisset; Vincent Tiffreau; Severine Denis; Virginie Jousten; Susana Quijano-Roy; Thomas Voit; Jean-Yves Hogrel; Laurent Servais
Journal:  PLoS One       Date:  2015-02-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.